Pfizer Drug Shows Promise in Slowing Down Breast Cancer Progression

by Kathy Jones on  April 8, 2014 at 10:36 PM Cancer News
RSS Email Print This Page Comment
Font : A-A+

Experts suggest that an experimental cancer drug developed by Pfizer could provide a potential treatment in slowing down the spread of advanced breast cancer.
 Pfizer Drug Shows Promise in Slowing Down Breast Cancer Progression
Pfizer Drug Shows Promise in Slowing Down Breast Cancer Progression

The drug, called palbociclib, when administered with another anti-cancer drug already on the market, letrozole, stopped cancer progression for a median of 20 months.

That was double the amount of time seen in a control group of patients who did not receive palbociclib.

However, those on the two drugs survived an average of four months longer (37.5 months versus 33.3 months), which was not a statistically significant gain, the researchers noted.

More research is ongoing to measure the potential impact of the drug as a treatment for estrogen receptor positive and HER2 negative breast cancer.

The findings of the phase II trial, which included 165 women, were released Sunday at the American Association of Cancer Research in San Diego, California.

Source: AFP

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Women and Cancer Drug Toxicity Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Signature Drug Toxicity Breast Cancer Facts Cancer Facts Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive